|1.||Beutler, Bruce: 11 articles (01/2012 - 09/2004)|
|2.||Kindler-Röhrborn, Andrea: 9 articles (05/2015 - 06/2002)|
|3.||Fischer, Christine: 7 articles (05/2015 - 01/2006)|
|4.||Brown, Steve D M: 7 articles (12/2014 - 10/2006)|
|5.||Du, Xin: 7 articles (10/2013 - 09/2004)|
|6.||Mitsumori, Kunitoshi: 7 articles (01/2007 - 06/2002)|
|7.||Wolf, Eckhard: 6 articles (08/2013 - 01/2005)|
|8.||Rathkolb, Birgit: 6 articles (08/2013 - 01/2005)|
|9.||Fuchs, Helmut: 6 articles (08/2013 - 04/2005)|
|10.||Justice, Monica J: 6 articles (01/2013 - 09/2004)|
02/01/1985 - "Measured by the time to death with tumors as an index, nitrosoethylurea was the most potent carcinogen, followed by nitroso-2-hydroxyethylurea, which was less effective in males than in females. "
12/01/1977 - "Of four nitrosoureas administered to F344 rats that were offspring of mothers treated with ethylnitrosourea during pregnancy, 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea and its methyl derivative were particularly effective in blocking tumor development."
05/01/2006 - "In the present study, we used microarray analysis to compare the gene expression patterns of magnetic resonance imaging (MRI)-localized N-ethyl-N-nitrosourea (ENU)-induced tumors in rat brains with those of uninvolved contralateral side and normal brains. "
01/16/2006 - "In our previous study, microarray analysis was performed on N-ethyl-N-nitrosourea (ENU)-induced forestomach tumors in transgenic mice carrying the human prototype c-Ha-ras gene (ras H2 mice). "
11/01/2000 - "In our previous study, we established a uterine-carcinogenesis model that is useful for detecting tumor-modifying effects of EDCs by the administration of N-ethyl-N-nitrosourea (ENU) to female heterozygous p53-deficient CBA mice [p53 (+/-) mice]. "
04/01/1988 - "A combined dominant cataract-recessive specific locus mutation experiment for fractionated exposure to ethylnitrosourea (2 X 80 mg/kg, 24-h fractionation interval) was designed to determine if lower doses of ethylnitrosourea are more effective in inducing dominant cataract mutations as suggested by previous results. "
08/01/1986 - "These present results confirm previous results, which indicate that ethylnitrosourea is effective in inducing both recessive specific-locus and dominant cataract mutations although the per locus mutation rate to recessive alleles was observed to be approximately 6 times greater than the per locus mutation rate to dominant alleles. "
05/01/2009 - "This study analyzed genes associated with the morphology and regulation of ethylnitrosourea (ENU)-induced cataract mouse. "
05/01/2009 - "Characteristics of ethylnitrosourea-induced cataracts."
09/30/2008 - "A mouse with cataract, Kec, was generated from N-ethyl-N-nitrosourea (ENU) mutagenesis. "
01/20/2012 - "Using N-ethyl-N-nitrosourea mutagenesis in mice, we identified a mutant with increased resistance to viral infections because of the presence of hyperresponsive NK cells. "
05/25/2010 - "A previously unappreciated signal necessary for dendritic cell (DC)-mediated activation of natural killer (NK) cells during viral infection was revealed by a recessive N-ethyl-N-nitrosourea-induced mutation called warmflash (wmfl). "
03/01/1985 - "Cells which had been sublethally UV irradiated prior to infection, were able to overcome about 20% of the delayed lethal hits inflicted to ethylnitrosourea-treated H-1. "
02/01/2015 - "We identify an N-ethyl-N-nitrosourea (ENU)-induced I23N mutation in the THEMIS protein that causes protection against experimental cerebral malaria (ECM) caused by infection with Plasmodium berghei ANKA. "
11/01/2015 - "In the present study, the response to malaria infection was examined in a mutant mouse line, Tfrc(MRI24910), identified during an N-ethyl-N-nitrosourea (ENU) screen. "
01/01/2012 - "Mice with ethylnitrosourea- (ENU) induced leukemia were here used to monitor the therapeutic efficacy of lipopolysaccaride (LPS), Bacillus Calmette Guerin (BCG) and sheep erythrocytes (SRBC). "
07/01/1986 - "Spontaneous colony-forming activity in vitro and comparative histological studies on ethylnitrosourea-induced leukemia in Sprague-Dawley rats."
07/01/1982 - "Histological and cytological study on ethylnitrosourea-induced panmyelosis and acute leukemias in Sprague-Dawley rats."
04/01/1974 - "[Leukemia L 5222 of the rat strain BD IX. An ethylnitrosourea-induced monocytic-myeloic transplantable form for cytochemical and chemotherapeutic studies]."
12/01/2010 - "The mice were injected intraperitoneally with N-N' ethylnitrosourea (ENU) to induce leukemia; the mice received injection of normal saline were used as control. "
05/01/2006 - "A point mutation of the neu/erbB-2 gene diagnostic of N-ethyl-N-nitrosourea-induced rat schwannomas is an early marker of Schwann precursor cells at high risk of subsequent malignant transformation. "
05/01/2006 - "Contrary to rats of the highly sensitive inbred strain BDIX, BDIV rats are resistant to the induction of malignant schwannomas by N-ethyl-N-nitrosourea, arising predominantly in the trigeminal nerves. "
09/01/2000 - "Contrary to the response of rats of the highly sensitive inbred strain BDIX, BDIV rats are resistant to the induction of malignant schwannomas by exposure to the alkylating N-nitroso carcinogen N-ethyl-N-nitrosourea (EtNU). "
09/01/2000 - "Suppression of ethylnitrosourea-induced schwannoma development involves elimination of neu/erbB-2 mutant premalignant cells in the resistant BDIV rat strain."
12/01/1999 - "Activation of neu by missense point mutation in the transmembrane domain in schwannomas induced in C3H/HeNCr mice by transplacental exposure to N-nitrosoethylurea."
|2.||Nerve Growth Factor (NGF)
|3.||Toll-Like Receptor 2
|5.||Tretinoin (Retinoic Acid)
|6.||Glial Fibrillary Acidic Protein
|1.||Drug Therapy (Chemotherapy)
|2.||Transplantation (Transplant Recipients)